Article

Pulmonary surfactant-based inhalable nanoparticles for folate receptor- targeted delivery and macrophage reprogramming in lung cancer

2026-07-15

Abstract excerpt

<title>Abstract</title> <p>Background Lung cancer remains a leading cause of cancer-related death, and chemotherapy is often limited by systemic toxicity and insufficient drug accumulation in lung tumors. Inhalable nanomedicine offers a route to address these limitations, but nanoparticle systems remain limited by poor nebulization stability, rapid macrophage-mediated clearance, and an immunosuppressive tumor mi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6f014639-2749-55f2-8472-f268a81ee258
DOI: 10.21203/rs.3.rs-10278660/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pulmonary surfactant-based inhalable nanoparticles for folate receptor- targeted delivery and macrophage reprogramming in lung cancerDOI 10.21203/rs.3.rs-10278660/v1Read

Advancements in gene therapy for lung cancer: from genetic insights to clinical applicationsSemantic proximity Read

Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.Semantic proximity Read

Lung surfactants as a component of lipid nanoparticles for pulmonary mRNA deliverySemantic proximity Read

Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancerSemantic proximity Read

Enhanced lung delivery of an immunostimulatory duplex RNA augments the antitumor activity by reshaping systemic cytokine pharmacodynamicsSemantic proximity Read

Nanomedicine Strategies for Management of Drug Resistance in Lung CancerSemantic proximity Read

Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer.Semantic proximity Read

Zwitterionic Inhaler with Synergistic Therapeutics for Reprogramming of M2 Macrophage to Pro-Inflammatory Phenotype.Semantic proximity Read

<p>Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)</p>.Semantic proximity Read

The Advancement in Magnetic Nanoparticles for the Diagnosis of Lung Cancer and Its MonitoringSemantic proximity Read

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer.Semantic proximity Read

Ultrasound-mediated PLGA-PEI Nanobubbles Carrying STAT6 SiRNA Enhances NSCLC Treatment via Repolarizing Tumor-associated Macrophages from M2 to M1 Phenotypes.Semantic proximity Read